Neoadjuvant 5 Fluorouracil-Cisplatin Chemoradiation Effect on Survival in Patients with Resectable Pancreatic Head Adenocarcinoma: A Ten-Year Single Institution ExperienceTurrini O. · Viret F. · Moureau-Zabotto L. · Guiramand J. · Moutardier V. · Lelong B. · de Chaisemartin C. · Giovannini M. · Delpero J.-R.
Departments of aSurgical Oncology, bMedical Oncology, cRadiotherapy, and dEndoscopy, Institut Paoli-Calmettes and Université de la Méditerranée Marseille, Marseille, France
Objectives: It is the aim of this study to assess the outcome of patients who received neoadjuvant 5-fluorouracil-cisplatin chemoradiation (CRT) for stage I/III pancreatic adenocarcinoma. Methods: Eligible patients (n = 101) received radiation therapy (45 Gy) associated with continuous infusion of 5-fluorouracil accompanied by a cisplatin bolus. Results: Of the 102 patients enrolled in the study, 26 patients had progression of cancer during treatment and were deemed unresectable; 1 patient died during CRT of septic shock. Sixty-two of 75 remaining patients underwent pancreaticoduodenectomy. The overall median survival of all 102 patients in the study was 17 months, with a 5-year survival of 10%. For patients who underwent resection, the median survival was 23 months. Correspondingly, the median survival was 11 months for the 40 unresected patients (p = 0.002). The 5-year survivals for resected and unresected patients were 18 and 0% (p = 0.01), respectively. A complete pathological response to neoadjuvant CRT was noted for 8 patients (13%). Margin and lymph node positivity was present in 5 (8%) and 15 (24%) patients, respectively. There was documented local recurrence in 8 (13%) and distant recurrence in 36 (58%) patients, with the liver being the most common site. Conclusion: Neoadjuvant 5-fluorouracil-based CRT had a limited impact on survival but appeared to be associated with improved local control.
232, Bd de Sainte Marguerite
FR–13009 Marseille (France)
Tel. +33 491 22 36 60, Fax +33 491 22 35 50, E-Mail firstname.lastname@example.org
Received: October 13, 2008
Accepted after revision: December 18, 2008
Published online: May 4, 2009
Number of Print Pages : 7
Number of Figures : 2, Number of Tables : 4, Number of References : 30
Oncology (International Journal of Cancer Research and Treatment)
Vol. 76, No. 6, Year 2009 (Cover Date: May 2009)
Journal Editor: Markman M. (Houston, Tex.)
ISSN: 0030-2414 (Print), eISSN: 1423-0232 (Online)
For additional information: http://www.karger.com/OCL